US Edition
TriCares Topaz TTVR System Evaluated in TRICURE FIH Study - Cardiac Interventions Today
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
TriCares Topaz TTVR System Evaluated in TRICURE FIH Study - Cardiac Interventions Today
May 27, 2025—TriCares SAS recently announced the presentation of data from the TRICURE first-in-human (FIH) trial of its investigational Topaz transcatheter tricuspid valve replacement (TTVR) system. The 30-day postprocedural data were from 20 tricuspid regurgitation (TR) patients treated with the Topaz device at eight specialist cardiac centers in Europe. The findings were presented by Julien Dreyfus, MD, in a late-breaking session at the EuroP…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
